Enabling Sensitive Biologics With the SCHOTT TOPPAC® cartridge and a Large-Volume Autoinjector Platform
Information
As the biologics landscape evolves, increasingly complex formulations are placing new demands on primary packaging and delivery devices. To meet these needs, SCHOTT Pharma is introducing
SCHOTT TOPPAC® cartridge, the first ready-to-use (RTU) polymer cartridge platform. Leveraging Cyclic Olefin Copolymer (COC) technology, SCHOTT TOPPAC® cartridge overcomes key limitations of conventional packaging with tight dimensional tolerances.
To enable seamless adoption of this novel cartridge technology, SCHOTT Pharma has collaborated with SHL Medical to ensure full compatibility with SHL Medical’s Maggie® 3.0 mL and 5.0 mL autoinjector platforms. Together, the SCHOTT TOPPAC® cartridge and the Maggie® platform create a robust, scalable, and future-ready solution for emerging biologics.
